Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women

NCT ID: NCT06360536

Last Updated: 2026-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-04

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect preliminary data on the feasibility, acceptability, and potential effects of a novel, remotely delivered resistance training program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This trial will enroll Black women with elevated cardiometabolic risk (e.g., overweight or obesity, pre- or established diabetes, and elevated or high blood pressure) in early-to-middle adulthood (n=36; age=30-64 years) with insufficient resistance training (RT) participation. This 4-month single group pilot trial evaluates the feasibility, acceptability, and potential effects of a novel, remotely-delivered resistance training (RT) intervention. All participants will engage in RT during this trial and the web-based platform is the primary modality through which the remote RT intervention is delivered. Assessments are conducted at baseline and follow-up (month 4). Aim 1 will examine the feasibility and acceptability of the remotely delivered RT program. Aim 2 will examine the potential effects on RT behaviors. Aim 3 will examine the potential effects on clinical and patient-reported outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overweight or Obesity Prediabetes or Diabetes Prehypertension (Elevated Blood Pressure) or Hypertension Resistance Training

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention/Treatment

A home-based resistance training condition that is delivered through a web-based platform.

Group Type EXPERIMENTAL

Resistance Training

Intervention Type BEHAVIORAL

A home-based resistance training condition that is delivered through a web-based platform.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resistance Training

A home-based resistance training condition that is delivered through a web-based platform.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

RT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Self-identifies as Black or African American
* Female
* Age 30-64 years
* Insufficient resistance training engagement (\<2 sessions/week in the past 6 months)

AND

* Self-reported or documented diagnosis of at least one of the following conditions: Overweight, obesity, prediabetes, type 2 diabetes, elevated blood pressure, hypertension, or taking medications for any of these conditions
* Has an internet- connected device (i.e., computer, smartphone) and is willing to use it for intervention delivery
* If indicated during screening, willing to obtain medical clearance for exercise from their healthcare provider prior to enrollment
* Residing within a 50-mile radius of the University

Exclusion Criteria

* Uncontrolled hypertension (blood pressure \>160/100 mm Hg)
* Weighing ≥ 450 lbs (upper limit for body composition assessment)
* Conditions or limitations that affect physical activity participation and/or the ability to --perform assessments
* Has a medical or physical condition that make moderate intensity physical activity (like a brisk walk) difficult or unsafe
* Unwilling to obtain medical clearance (if indicated by prescreening)
* Women who are pregnant or trying to become pregnant in the next 6 months
* Planning to relocate out of the area in the next 6 months
* Participating in another exercise and/or randomized research project
* Unwilling or unable to do any of the following: give informed consent; read/understand English; perform resistance training in their home, record and upload virtual exercise assessment sessions, and other protocol specific requirements
Minimum Eligible Age

30 Years

Maximum Eligible Age

64 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

Sponsor Role collaborator

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amber W. Kinsey, PhD

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amber W Kinsey, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sarahi Hernandez, MPH

Role: CONTACT

205-996-1638

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sarahi Hernandez, MPH

Role: primary

205-996-1638

Amber Kinsey, PhD

Role: backup

205-934-9851

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P50MD017338

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB-300012634

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise Resistance in Type 2 Diabetes
NCT01911104 ACTIVE_NOT_RECRUITING NA